Download Free Sample Report

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.
Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.
In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor?s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).
This report contains market size and forecasts of CRO in Clinical Trials in Global, including the following market information:

• Global CRO in Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global CRO in Clinical Trials market was valued at 44220 million in 2021 and is projected to reach US$ 81210 million by 2028, at a CAGR of 9.1% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Trial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRO in Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Phase I Trial
• Phase II Trial
• Phase III Trial
• Phase IV Trial

• Pharmaceutical
• Bio-pharm
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies CRO in Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies CRO in Clinical Trials revenues share in global market, 2021 (%)

• Labcorp
• IQVIA
• Parexel
• Syneos Health
• PRA Health Sciences
• PPD
• ICON
• MedPace
• Wuxi AppTec